Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Cornish elderly care scheme to increase pharmacy's role

An Age UK-led initiative is considering a "variety of approaches" for pharmacists to assist patients with two or more long-term conditions

EXCLUSIVE

An elderly care project in Cornwall wants to make greater use of pharmacists to treat patients with long-term conditions.

The Living Well scheme in Penwith, Newquay and east Cornwall has brought together representatives from health services, social care and the voluntary sector to support almost 1,600 patients with two or more long-term conditions or in social housing.

GP and chair of the scheme Matthew Boulter told C+D that it is now “toying with a variety of different approaches" to increase the involvement of community pharmacists.

As part of the scheme, launched by charity Age UK in Cornwall in 2014, Kernow clinical commissioning group (CCG) has funded pharmacists to visit the homes of elderly patients who have been prescribed “double figures of medicines”, he said.

The project's team has also placed a community pharmacy representative on the geriatric ward of Newquay Hospital to monitor patients' medicines, Dr Boulter said.

“Patients are confused with their medicines and don’t know what they’re on. The traditional role is to approach the GP, but now we’re going to send people straight to the pharmacist,” he said.

"Latecomer to the party"

Pharmacy was a “latecomer to the party” but it “definitely" has a role in the project, Dr Boulter stressed.

Closer collaboration between GPs and pharmacists is “well overdue”, Dr Boulter added. “The only time I used to speak to a pharmacist would be when I did something wrong, but now we are having constructive conversations about medicines rather than fire-fighting errors that [GPs] make.”

Cornwall and Isles of Scilly LPC chief officer Phillip Yelling told C+D that as well as home visits, pharmacists are working with Living Well volunteers "to provide support to their clients”. 

The LPC has had limited involvement with the initiative so far but is “working to make that better in the future”, he said. “Living Well can identify the medicines issues and refer them back to the pharmacists to sort them out,” he added.

Living Well was developed by Age UK – which runs similar schemes across England – and is funded from the government’s £5.3 billion Better Care Fund.

The Cornish Living Well initiative announced last Friday (August 21) that it achieved a 34% reduction in local emergency hospital admissions between January 2014 and January 2015.

Pharmacy minister Alistair Burt said he was delighted by the “excellent results” and praised Cornwall for “leading the way” in joining up health and social care services. 

 


Hpw do you provide joined-up care for elderly patients? 

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007648

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel